APA

Doualla-Bell F., Avalos A., Gaolathe T., Mine M., Gaseitsiwe S., Ndwapi N., Novitsky V. A., Brenner B., Oliveira M., Moisi D., Moffat H., Thior I., Essex M. & Wainberg M. A. (20060801). Impact of human immunodeficiency virus type 1 subtype C on drug resistance mutations in patients from Botswana failing a nelfinavir-containing regimen. : Antimicrobial agents and chemotherapy.

Chicago

Doualla-Bell Florence, Avalos Ava, Gaolathe Tendani, Mine Madisa, Gaseitsiwe Simani, Ndwapi Ndwapi, Novitsky Vladimir A, Brenner Bluma, Oliveira Maureen, Moisi Daniella, Moffat Howard, Thior Ibou, Essex Max and Wainberg Mark A. 20060801. Impact of human immunodeficiency virus type 1 subtype C on drug resistance mutations in patients from Botswana failing a nelfinavir-containing regimen. : Antimicrobial agents and chemotherapy.

Harvard

Doualla-Bell F., Avalos A., Gaolathe T., Mine M., Gaseitsiwe S., Ndwapi N., Novitsky V. A., Brenner B., Oliveira M., Moisi D., Moffat H., Thior I., Essex M. and Wainberg M. A. (20060801). Impact of human immunodeficiency virus type 1 subtype C on drug resistance mutations in patients from Botswana failing a nelfinavir-containing regimen. : Antimicrobial agents and chemotherapy.

MLA

Doualla-Bell Florence, Avalos Ava, Gaolathe Tendani, Mine Madisa, Gaseitsiwe Simani, Ndwapi Ndwapi, Novitsky Vladimir A, Brenner Bluma, Oliveira Maureen, Moisi Daniella, Moffat Howard, Thior Ibou, Essex Max and Wainberg Mark A. Impact of human immunodeficiency virus type 1 subtype C on drug resistance mutations in patients from Botswana failing a nelfinavir-containing regimen. : Antimicrobial agents and chemotherapy. 20060801.